Investors Title Company ITIC Q4 2025 Earnings Strong EPS of 397 Amid Quiet Quarter Annovis Bio Q1 2026 Earnings EPS Misses Estimates as PreClinical Spending Intensifies TSLA Q1 2026 Earnings EPS Beats Estimates as Tesla Delivers Profitability Surprise NGNE Q1 2026 Earnings EPS Falls Short of Consensus as PreRevenue Biotech Maintains RD Focus BAER Q1 2026 Earnings EPS Miss of 537 with Uptick in Stock Price HEI Q1 2026 Earnings EPS Surpasses Estimates Stock Gains 26